Journal
MOLECULAR CELL
Volume 25, Issue 1, Pages 57-70Publisher
CELL PRESS
DOI: 10.1016/j.molcel.2006.11.022
Keywords
-
Categories
Funding
- NCI NIH HHS [CA52599, R01 CA052599] Funding Source: Medline
- NHLBI NIH HHS [HL56989, P50 HL056989] Funding Source: Medline
- NIDDK NIH HHS [R01 DK091183, DK063491, P30 DK063491] Funding Source: Medline
- NIGMS NIH HHS [U54 GM069338, GM 069338] Funding Source: Medline
Ask authors/readers for more resources
Transrepression is widely utilized to negatively regulate gene expression, but the mechanisms by which different nuclear receptors effect gene and signal-specific transrepression programs remain poorly understood. Here, we report the identification of alternative SUMOylation-dependent mechanisms that enable PPAR gamma and LXRs to negatively regulate overlapping but distinct subsets of proinflammatory genes. Ligand-dependent conjugation of SUMO2/3 to LXRs or SUMO1 to PPAR gamma targets them to promoters of TLR target genes, where they prevent the signal-dependent removal of NCoR corepressor complexes required for transcriptional activation. SUMO1-PPAR gamma and SUMO2/3LXRs inhibit distinct NCoR clearance mechanisms, allowing promoter- and TLR-specific patterns of repression. Mutational analysis and studies of naturally occurring oxysterol ligands indicate that the transactivation and SUMOylation-dependent transrepression activities of LXRs can be independently regulated. These studies define parallel but functionally distinct pathways that are utilized by PPAR gamma and LXRs to differentially regulate complex programs of gene expression that control immunity and homeostasis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available